Bildkälla: Stockfoto

XVIVO Perfusion: The European study is a confirmation of the success in Australia and New Zeeland - Redeye

XVIVO presented the overall results from the European Heart study, based on 203 patients across 15 centers in 8 countries. The actual results are a robust improvement compared with the standard of care, and we look forward to a formal approval and launch in late 2024.

XVIVO presented the overall results from the European Heart study, based on 203 patients across 15 centers in 8 countries. The actual results are a robust improvement compared with the standard of care, and we look forward to a formal approval and launch in late 2024.
Börsvärldens nyhetsbrev
ANNONSER